Akcea Therapeutics Inc (AKCA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Akcea Therapeutics Inc   (NASDAQ: AKCA)

Akcea Therapeutics Inc

Officers & Directors


1. Peter K. M. Smith - Chairman of the Board
2. Paula Soteropoulos - Director
3. Michael Richman - Director
4. Jonathan Kusminsky - Director
5. W. Don Cornwell - Director
6. Dushyant Pathak - Director
Louis O'Dea - Director

Executive Officers:

1. Damien McDevitt - Chief Executive Officer
2. Sarah Boyce - President and Chief Operating Officer
3. Akshay Vaishnaw - Executive Vice President and Head of Research and Development
4. Jeff Goldberg - Chief Medical Officer and Senior Vice President
5. Michael Nash - Chief Financial Officer
6. Paula Soteropoulos - Senior Vice President and Chief Business Officer.

Akcea Therapeutics Inc currently has 207 employees.






AKCA Management Effectiveness AKCA Revenue per Employee AKCA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.